The U.S. Court of Appeals for the Federal Circuit (CAFC) issued a precedential decision on Tuesday, January 20, concluding that a district court abused its discretion in granting motions to exclude two of Dr. Mark A. Barry’s experts and granting judgment as a matter of law (JMOL) to DePuy Synthes Companies. The panel included Judges Stark, Taranto and Prost and Judge Stark dissented. Barry’s U.S. Patent Nos. 7,670,358; 8,361,121; and 9,668,787 cover “surgical techniques and tools for treating spinal deformities, such as scoliosis, that cause vertebrae, which are the small bones forming the backbone, to twist out of alignment,” according to the opinion.
In the latest episode of IPWatchdog Unleashed, I sat down with my good friends Brad Close, who is the Executive Vice President of Transpacific IP, and Jim Carmichael, a former judge on the Board of Patent Appeals and Interferences and founder of Carmichael IP. Brad, Jim and I engaged in a candid conversation that provides our unvarnished assessment of the Patent Trial and Appeal Board (PTAB), where it started historically, where it is today, and where it may finally be headed. Bottom line: the PTAB is no longer the automatic execution squad it once was, but durable patent rights will require reform well beyond the agency level.
U.S. Patent and Trademark Office (USPTO) Director John Squires on January 15 issued a Director Review decision, which he then designated as informative on January 16, in favor of Micron Technologies, vacating two Patent Trial and Appeal Board (PTAB) decisions granting institution of inter partes review (IPR) for Yangtze Memory Technologies. The decision addressed the issue of real party in interest (RPI), which Squires said Micron had sufficiently disputed, while Yangtze failed to rebut the evidence presented and show that it had named all RPIs.
On Friday, the U.S. Supreme Court granted certiorari to a petition filed by patent owner Hikma Pharmaceuticals, taking up Hikma’s appeal of the U.S. Court of Appeals for the Federal Circuit’s ruling from June 2024 finding that Amarin Pharma plausibly alleged patent infringement against Hikma’s generic omega-3 fatty acid product. The decision indicates that the nation’s highest court may be willing to overturn the Federal Circuit’s finding that Hikma’s U.S. Food & Drug Administration (FDA) -approved skinny label induced infringement in light of Hikma’s public statements about its generic product.
As we wind down 2025 it is time to reflect on the year that was, and what the future will bring. This year was punctuated by a structural reset for the U.S. patent system. What unfolded was not just incremental reform, but a coordinated shift driven by leadership change, policy realignment, economic pressure, and accelerating adoption of AI—all converging to reshape how patents are examined, challenged, monetized, and managed. This week on IPWatchdog Unleashed we explore the monumental changes and the biggest trends that impacted the patent and innovation industry during 2025, and which will play an important role in defining 2026.
In the latest episode of IPWatchdog Unleashed, I sat down with my good friends Brad Close, who is the Executive Vice President of Transpacific IP, and Jim Carmichael, a former judge on the Board of Patent Appeals and Interferences and founder of Carmichael IP. Brad, Jim and I engaged in a candid conversation that provides our unvarnished assessment of the Patent Trial and Appeal Board (PTAB), where it started historically, where it is today, and where it may finally be headed. Bottom line: the PTAB is no longer the automatic execution squad it once was, but durable patent rights will require reform well beyond the agency level.
This week on IPWatchdog Unleashed, I sat down with prolific inventor Gil Hyatt, exploring his innovative journey and aspirations to leave a lasting legacy. One of the key highlights of the conversation was Gil’s creation of a non-profit Pioneering AI Foundation, which is aimed at advancing AI technology and bolstering U.S. economic interests. This non-profit organization is set to hold Gil’s substantial portfolio of AI patent applications, which cover his pioneering work dating back to the 1980s, and includes groundbreaking claims in artificial intelligence that could revolutionize sectors like education, manufacturing, and trade.
This week in Other Barks & Bites: The Sixth Circuit affirms a dismissal of a declaratory judgment suit after finding no federal question of law raised by the suit’s copyright allegations; the EU’s highest court says that EU member states can pass rules implementing a private copying levy against manufacturers of computer hard drive storage; the governments of the United States and Taiwan announce a relaxation of some reciprocal tariffs in response for a $250 billion investment in American chip capacity; creators and copyright owners in South Korea raise concerns over the opt-out framework proposed by South Korean lawmakers in that nation’s AI Action Plan; the Fifth Circuit finds no territoriality issue with the global grant of copyright declared for the 1966 single “Double Shot (Of My Baby’s Love)”; and the USPTO announces a program to offer accelerated examination certificates to companies engaging in technological standards development.
A group of conservative leaders on Wednesday sent a letter to the Director of the National Economic Council, Kevin Hassett, and Chief of Staff to President Trump, Susie Wiles, strongly supporting the U.S. Patent and Trademark Office’s (USPTO’s) Notice of Proposed Rulemaking (NPRM) issued in October, titled “Revision to Rules of Practice before the Patent Trial and Appeal Board.” The NPRM modifies the rules of practice for inter partes reviews (IPRs) before the Patent Trial and Appeal Board (PTAB), with the stated goal being “to focus inter partes review proceedings on patent claims that have not previously been challenged in litigation or where prior litigation was resolved at an early stage.” The deadline for comments was December 2 and the Office has received 11,442 total submissions.
There are lots of familiar recommendations to make U.S. businesses more competitive globally. All are valid, but none are particularly creative or original. One solution that hasn’t been pursued is not only simple, a variation of it has been implemented by America’s largest and most aggressive economic competitor: remove the filing fees for inventors and intellectual property (IP)creators under 18.
This week on IPWatchdog Unleashed, I sat down with my business and life partner, Renee Quinn. In addition to telling Renee’s story about how she found her way into the intellectual property world, and through our sometimes-comical banter, we together explore what it really takes to build, sustain, and continuously reinvent an entrepreneurial company like IPWatchdog. What emerged was a practical roadmap for entrepreneurship, invention, navigating platform risk, and focused on the necessity of constantly being ready to pivot as old business models start to show signs of age and ultimately falter. From Renee’s journey from IP outsider to patented inventor, to firsthand lessons learned navigating Amazon’s reseller ecosystem, the discussion highlights how intellectual property operates in the real world, not the classroom.
There’s a lot going on at the Patent Trial and Appeal Board (PTAB) right now, and it’s not just the usual noise about discretionary denial. The United States Patent and Trademark Office (USPTO) has published a one-and-done rules package that, if it survives, would fundamentally change how inter partes review (IPR) challenge works, who can challenge patents, and when. The comment window on the proposed one-and-done rule has now closed. With more than 10,000 comments received by the USPTO and over 700 individual commenters weighing in, the proposed rules package has become a flashpoint for questions that go way beyond discretionary denial and AIA trials, with many asking whether the USPTO is functionally trying to engage in de facto legislation to neuter the PTAB.
This week on IPWatchdog Unleashed, I was joined by my longtime friend John White, who is the the creator of the patent bar review course I’ve taught for almost 27 years. Together we explore the intricate and ever changing patent landscape. First, we begin by discussing the bar exam and how it is changing, then we pivot to the evolving role of AI in patent law more generally. Our conversation traversed decades of personal history, friendship and professional insights, revealing how the industry has transformed over the years and what it means for the current and future generation of patent practitioners.
This is the best way to stay informed. We send a daily roundup of our latest news, press releases, and events.
Get Email Updates